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Using	data	from	the	2000–2004	US	Healthcare	Cost	
and	Utilization	Project	National	Inpatient	Sample,	we	found	
that total hospital admissions for skin and soft tissue infec-
tions	increased	by	29%	during	2000–2004;	admissions	for	
pneumonia were largely unchanged. These results are con-
sistent with recent reported increases in community-associ-
ated methicillin-resistant Staphylococcus aureus infections.
D
uring  1998–2004,  Staphylococcus  aureus  was  the 
most common cause of skin and soft tissue infections 
(SSTIs) in North America; frequency of these infections 
was 44.6%, and the rate of methicillin resistance among 
the isolates was 35.9% (1). Over the past decade, com-
munity-associated  methicillin-resistant  S.  aureus  (CA-
MRSA) has become a notable public health problem; it 
accounts for 14% of invasive infections nationwide and 
59% (range 15%–74%) of SSTIs among patients seek-
ing treatment at emergency departments in 11 US cities 
(2,3). The emergence of CA-MRSA infections may have 
resulted in increased numbers of hospitalizations for SS-
TIs because of an increasing incidence of antimicrobial 
drug failure in outpatient treatment and more aggressive 
approaches to the management of these infections by phy-
sicians who are aware of the heightened risk of becoming 
infected with CA-MRSA. To determine whether hospital 
admissions for CA-MRSA are increasing, we analyzed 
data from the Healthcare Cost and Utilization Project Na-
tional Inpatient Sample.
The Study 
This study was based on data from the Healthcare Cost 
and Utilization Project National Inpatient Sample (HCUP 
NIS) for the 5-year period 2000–2004. HCUP NIS is a 
stratified random sample from ≈20% of all US community 
hospitals. For 2004, the NIS contains all discharge data 
from >1,000 acute-care hospitals in 37 states, representing 
>8 million hospital stays.
We identified all hospital admissions in the HCUP NIS 
for which a principal diagnosis of SSTI was given. As de-
fined by the Uniform Hospital Discharge Data Set, prin-
cipal diagnosis is the condition “established after study to 
be chiefly responsible for occasioning the admission of the 
patient to the hospital for care” (http://wonder.cdc.gov).
SSTIs were defined as the following: 1) acute lymph-
adenitis (International Classification of Diseases, 9th Revi-
sion, Clinical Modification [ICD-9-CM] 683.XX); 2) car-
buncle and furuncle (680.XX); 3) cellulitis and abscess of 
finger and toe (681.XX); 4) impetigo (684.XX); 5) infection 
(chronic) of amputation stump (997.62); 6) other cellulitis 
and abscess (682.XX); 7) other local infections of skin and 
subcutaneous tissue (686.XX); 8) abscess of anal and rec-
tal regions (566); 9) chronic ulcer of other specified sites 
(707.8); 10) chronic ulcer of unspecified site (707.9); 11) de-
cubitus ulcer (707); 12) infection due to other vascular device 
implant and graft (996.62); 13) pilonidal cyst with abscess 
(685); 14) postoperative wound infection (998.5X); 15) post-
traumatic wound infection, not elsewhere classified (958.3); 
16) ulcers of lower limbs, except decubitus (707.1X); 17) 
gangrene (785.4); and 18) necrotizing fasciitis (728.86).
To aid in interpretation of the data, we grouped the 
above-listed SSTIs into 3 mutually exclusive categories: 1) 
superficial infections predominantly caused by S. aureus or 
Streptococcus pyogenes (groups 1–7 above); 2); deeper or 
healthcare-associated infections more likely to involve an-
aerobic or gram-negative organisms (groups 8–16); and 3) 
infections typically associated with a high rate of mortality 
(groups 17–18). For each year of interest, all SSTI admis-
sions were then stratified by type of infection and selected 
patient and hospital characteristics.
To  provide  a  benchmark  against  which  to  interpret 
possible  trends  in  SSTI-related  hospital  admissions,  we 
generated similar series for all admissions with a princi-
pal diagnosis of infectious pneumonia, another common 
type of infection that frequently results in hospitalization 
but for which no trends were expected. Infectious pneu-
monia was defined to include 1) pneumococcal pneumonia 
(ICD-9-CM 481); 2) other bacterial pneumonia (482.XX) 
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Table	1.	Estimated	total	number	of	US	hospital	admissions	for	SSTIs	and	infectious	pneumonia,	2000–2004*	
Principal	diagnosis	 2000 2001 2002 2003 2004 Change	from	2000	to	2004
SSTI 674,939 701,672 757,858 810,768 869,777 194,838	(+28.9%)	
Infectious pneumonia  1,202,387 1,177,972 1,229,204 1,272,686 1,172,304 –30,083	(–2.5%)	
*SSTI,	skin	and	soft	tissue	infection.	Source:	Healthcare	Cost	and	Utilization	Project	National	Inpatient	Sample,	2000–2004.	Admissions	for	Skin	and	Soft	Tissue	Infections
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Table	2.	Number	of	hospital	admissions	with	principal	diagnosis	of	SSTI,	by	patient and infection characteristics and year* 
Year 
Characteristics
2000
(N	=	674,939)	
2001
(N	=	701,672)	
2002
(N	=	757,858)	
2003
(N	=	801,768)	
2004
(N	=	869,777)	
Age, y†	
	 <15	 38,420	(5.7)	 38,741	(5.5)	 44,559	(5.9)	 49,902	(6.2)	 56,909	(6.5)	
	 15–44	 176,574	(26.2)	 175,921	(25.1)	 197,142	(26.0)	 214,606	(26.5)	 240,971	(27.7)	
	 45–64	 212,367	(31.5)	 219,222	(31.2)	 247,079	(32.6)	 267,556	(33.0)	 289,715	(33.3)	
>65 247,544	(36.7)	 267,768	(38.2)	 269,048	(35.5)	 277,828	(34.3)	 281,288	(32.3)	
Sex†	
  Male  341,040	(50.5)	 347,784	(49.6)	 381,763	(50.4)	 406,525	(50.1)	 443,325	(51.0)	
	 Female	 333,771	(49.5)	 353,849	(50.4)	 376,075	(49.6)	 400,737	(49.4)	 423,255	(48.7)	
Race†
  White  364,634	(54.0)	 368,901	(52.6)	 372,013	(49.1)	 409,037	(50.5)	 439,295	(50.5)	
  Black  81,654	(12.1)	 81,299	(11.6)	 94,307	(12.4)	 99,892	(12.3)	 111,416	(12.8)	
	 Hispanic/Latino	 57,217	(8.5)	 59,345	(8.5)	 63,657	(8.4)	 78,091	(9.6)	 75,142	(8.6)	
	 Asian	or	Pacific	Islander	 6,457	(1.0)	 7,219	(1.0)	 8,496	(1.1)	 9,366	(1.2)	 10,053	(1.2)	
	 Native	American	 2,082	(0.3)	 2,375	(0.3)	 2,211	(0.3)	 1,595	(0.2)	 3,890	(0.5)	
	 Other	 11,873	(1.8)	 11,233	(1.6)	 16,304	(2.2)	 14,135	(1.7)	 13,937	(1.6)	
Infection	type	(ICD-9-CM	diagnosis	code[s])	
	 Superficial	infections	 390,158	(57.8)	 404,536	(57.7)	 440,501	(58.1)	 479,222	(59.1)	 520,099	(59.8)	
	 	 Acute	lymphadenitis	(683.XX)	 4,570	(0.7)	 4,341	(0.6)	 4,230	(0.6)	 4,324	(0.5)	 4,291	(0.5)	
	 	 Carbuncle	and	furuncle	(680.XX)	 1,001	(0.2)	 1,182	(0.2)	 1,349	(0.2)	 1,900	(0.2)	 2,298	(0.3)	
	 	 Cellulitis	and	abscess	of	finger	and	toe	
	 	 (681.XX)	
20,060	(3.0)	 20,868	(3.0)	 22,731	(3.0)	 25,174	(3.1)	 27,833	(3.2)	
	 	 Impetigo	(684.XX)	 1,221	(0.2)	 1,084	(0.2)	 1,250	(0.2)	 1,337	(0.2)	 1,481	(0.2)	
	 	 Infection	(chronic)	of	amputation	stump		
	 	 (997.62)	
13,431	(2.0)	 14,874	(2.1)	 15,100	(2.0)	 14,459	(1.8)	 16,014	(1.8)	
	 	 Other	cellulitis	and	abscess	(682.XX)	 346,270	(51.3)	 358,884	(51.2)	 392,422	(51.8)	 428,274	(52.8)	 464,016	(53.4)	
	 	 Other	local	infections	of	skin	(686.XX)	 3,605	(0.5)	 3,302	(0.5)	 3,419	(0.5)	 3,755	(0.5)	 4,167	(0.5)	
	 Deeper	and/or	healthcare-associated		
  infections 
274,549	(40.7)	 287,736	(41.0)	 307,300	(40.6)	 320,580	(39.5)	 339,337	(39.0)	
	 	 Abscess	of	anal	and	rectal	region	(566)	 20,511	(3.0)	 20,273	(2.9)	 22,772	(3.0)	 23,892	(3.0)	 24,655	(2.8)	
	 	 Chronic	ulcer	of	other	specified	sites		
	 	 (707.8)	
132	(0.0)	 75	(0.0)	 73	(0.0)	 68	(0.0)	 62	(0.0)	
	 	 Chronic	ulcer	of	unspecified	site		
	 	 (707.9)	
2,136	(0.3)	 2,191	(0.3)	 2,389	(0.3)	 2,666	(0.3)	 2,465	(0.3)	
	 	 Decubitis	ulcer	(707.0)	 37,116	(5.5)	 38,637	(5.5)	 36,816	(4.9)	 38,167	(4.7)	 39,706	(4.6)	
    Infection due to vascular device  
	 	 (996.62)	
64,262	(9.5)	 73,051	(10.4)	 78,289	(10.3)	 81,970	(10.1)	 91,804	(10.6)	
	 	 Pilonidal	cyst	with	abscess	(685.0)	 2,262	(0.3)	 2,167	(0.3)	 2,447	(0.3)	 2,496	(0.3)	 2,604	(0.3)	
	 	 Postoperative	wound	infection	(998.5X)	 115,694	(17.1)	 120,344	(17.2)	 134,783	(17.8)	 138,393	(17.1)	 144,768	(16.6)	
	 	 Posttraumatic	wound	infection,	NEC		
	 	 (958.3)	
2,748	(0.4)	 2,239	(0.3)	 1,664	(0.2)	 2,326	(0.3)	 2,843	(0.3)	
	 	 Ulcers	of	lower	limbs,	except	decubitis		
	 	 (707.1X)	
29,688	(4.4)	 28,759	(4.1)	 28,067	(3.7)	 30,602	(3.8)	 30,431	(3.5)	
	 Often	fatal	infections	 10,232	(1.5)	 9,400	(1.3)	 10,057	(1.3)	 10,965	(1.4)	 10,341	(1.2)	
	 	 Gangrene	(785.4)	 5,628	(0.8)	 4,814	(0.7)	 5,155	(0.7)	 5,546	(0.7)	 4,331	(0.5)	
	 	 Necrotizing	fasciitis	(728.86)	 4,604	(0.7)	 4,586	(0.7)	 4,902	(0.7)	 5,419	(0.7)	 6,010	(0.7)	
Hospital region
	 Northeast	 142,316	(21.1)	 155,948	(22.2)	 158,649	(20.9)	 174,481	(21.5)	 171,399	(19.7)	
  Midwest  152,132	(22.5)	 159,442	(22.7)	 173,353	(22.9)	 175,144	(21.6)	 193,602	(22.3)	
	 South	 253,388	(37.5)	 269,323	(38.4)	 297,122	(39.2)	 316,028	(39.0)	 351,721	(40.4)	
  West  127,102	(18.8)	 116,958	(16.7)	 128,734	(17.0)	 145,115	(17.9)	 153,056	(17.6)	
Hospital location†	
	 Urban	 570,554	(84.5)	 592,908	(84.5)	 645,261	(85.1)	 691,795	(85.3)	 755,095	(86.8)	
	 Rural	 103,664	(15.4)	 108,763	(15.5)	 112,597	(14.9)	 118,563	(14.6)	 114,682	(13.2)	
*SSTI,	skin	and	soft	tissue	infection;	ICD-9-CM,	International	Classification	of	Diseases,	9th	Revision,	Clinical	Modification;	NEC,	not	elsewhere	classified.	Numbers	
are	given	as	no.	(%)	admissions;	N	values	for	each	year	are	provided.	Source:	Healthcare	Cost	and	Utilization	Project	National	Inpatient	Sample,	2000–2004.	
†Percentages	may	not	add	up	to	100%	due	to	missing	data.	3); pneumonia caused by other specified organism (483.X) 
4); bronchopneumonia, organism unspecified (485); and 5) 
pneumonia, organism unspecified (486).
Analyses were directed at discerning possible trends in 
SSTI-related hospital admissions at US acute-care hospi-
tals over the 5-year period of study. Total SSTI admissions 
were estimated for each year by type of infection (i.e., su-
perficial, deeper or healthcare-associated, often-fatal). Re-
sults also were stratified according to patient (e.g., age, sex) 
and hospital characteristics (e.g., urban vs. rural) available 
in the HCUP NIS. For comparison, we also examined total 
hospital admissions for infectious pneumonia.
Because the HCUP NIS undergoes periodic changes in 
its sampling frame and weighting method, as well as in data 
elements and definitions, we used the NIS Trends Supple-
mental (NIS-Trends) files to ensure comparability of data 
across the years of interest. The NIS-Trends files contain 
sampling weights and data elements that are consistently 
defined across all years of interest.
Analyses were primarily descriptive (i.e., no a priori 
hypotheses were made, and our results were not subjected 
to formal significance testing). All analyses were conducted 
by using the SAS Proprietary Software, Release 9.1 (SAS 
Institute, Cary, NC, USA).
The estimated total number of annual SSTI admissions 
to US acute-care hospitals rose steadily over the 5-year pe-
riod, from 675,000 in 2000 to 869,800 in 2004, an increase 
of 194,000 (29%) admissions. In contrast, total admissions 
for infectious pneumonia fluctuated from year to year and 
were largely unchanged over this period (Table 1).
The increase in SSTI admissions was greatest among 
younger (age <65 years) rather than older patients (age 65–
100 years) (37% vs. 14%, respectively) and for urban rather 
than rural hospitals (32% vs. 11%) (Table 2). The increase 
in SSTI admissions also was greatest among patients with 
superficial infections (e.g., cellulitis, abscess) rather than 
deeper  or  healthcare-associated  infections  (e.g.,  postop-
erative wound infection, infection due to vascular device) 
(33% vs. 24%).
Conclusions
Until recently, CA-MRSA was relatively uncommon. 
In 2000, for example, these isolates accounted for only 3% 
of staphylococcal isolates submitted to Minnesota laborato-
ries (4). In recent years, however, CA-MRSA has become 
a major cause of SSTIs. The prevalence of MRSA among 
patients with SSTIs who sought treatment at 1 Los Angeles 
area emergency department increased from 29% in 2001 to 
64% in 2004 (5).
While the estimated total number of SSTI admissions 
to US acute-care hospitals increased by ≈29% during 2000–
2004, admissions for infectious pneumonia were largely 
unchanged. We are unaware of any other data to which our 
findings might be directly compared. Our results appear 
to be consistent, however, with those of previous studies 
that have reported an increasing prevalence of illness at-
tributable to S. aureus infections in general and to MRSA 
in particular (6,7). Although we could not establish in our 
study whether the increase in the number of SSTI hospi-
tal admissions was a result of the growing prevalence of 
CA-MRSA (the HCUP-NIS does not report microbiologic 
data), we suspect that the 2 phenomena are closely linked—
especially in light of the absence of any similar increase 
in hospital admissions for pneumonia, the most common 
community-associated infection requiring hospitalization. 
We therefore believe that the clinical and economic effects 
of CA-MRSA SSTIs are substantial and growing, and that 
this increase should be a focus of additional research.
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